LifeStance Health Group (LFST) has a profit margin of 3.63%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
LifeStance Health Group (LFST) currently reports a profit margin of 3.63% as of June 2026. That compares with -1.88% in the prior-year period — up 292.8% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore LifeStance Health Group's profit margin history and peer comparisons.
LifeStance Health Group's profit margin increased from -1.88% to 3.63% — a 292.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
LifeStance Health Group's profit margin of 3.63% is lower than the Healthcare sector average of 13.89%. That is roughly 73.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but LifeStance Health Group's current 3.63% should be judged against Healthcare norms (sector average: 13.89%) and against LFST's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 3.63%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for LifeStance Health Group, and consider following LFST for alerts when major investors trade the stock.